National Pharmacy Health & Leadership Alliance Verify a MemberMember Login

What changed today in Regulatory: 1 final rule

Every new official record on the Pharmacy, Compounding & Regulatory Intelligence desk since this morning, each linked to its primary source.

The signal

NPHLA tracked 1 new official record on this desk today: 1 final rule.

Why this matters

Federal Register documents and FDA notices can change compliance obligations, deadlines and enforcement priorities for pharmacies, compounders and prescribers.

What changed

  1. Final rule published: Improving Transparency Into Pharmacy Benefit Manager Fee Disclosure.[1]
  2. Also reported by Drug Topics: “American Pharmacists Month: PBM Reform, Provider Status Key in Stopping Pharmacy Deserts”.[2]

Who this affects

  • Pharmacies
  • 503A compounders
  • 503B outsourcing facilities
  • Pharmacists
  • Prescribers
  • Practice owners & operators

What to watch next

“Improving Transparency Into Pharmacy Benefit Manager Fee Disclosure” takes effect Jan 3, 2027[1]

NPHLA takeaway

These are factual summaries of official records with no interpretation. Open the primary documents for full details; NPHLA editors add analysis where developments warrant it.

Source file

  1. [1]
  2. [2]
    American Pharmacists Month: PBM Reform, Provider Status Key in Stopping Pharmacy Deserts (opens the source in a new tab)

    News reportingDrug TopicsIndustry coverage — headline and link only

Compiled automatically from primary official sources and peer-reviewed literature. Each line is a factual summary of a public record, linked to it — no interpretation is added. NPHLA links to sources and does not republish their text. Professional information only — not medical, legal or regulatory advice for any individual situation. Our standards.